A Study With Aleglitazar in Patients With a Recent Acute Coronary Syndrome and Type 2 Diabetes Mellitus
Clinical trial NCT01042769 · COMPLETED
Trial details
- NCT number
- NCT01042769
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-02-01
- Primary completion
- 2013-11-01
- Enrollment
- 7226
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.